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Muscle mass versus body mass index as predictor of
adverse outcome
Sarcopenia is a progressive skeletal muscle disorder, which is
characterized by low muscle mass and strength and
associated with increased risk of adverse outcomes, including
premature death.1 Despite improved awareness of the im-
portance of sarcopenia by health care professionals, funda-
mental findings from research lack translation to clinical
practice—a gap that must be bridged given the major per-
sonal, social, and economic burdens ensued by its presence.1
We report on a renal transplant recipient who experienced
substantial muscle wasting during 27.5 years of follow-up.
Height-indexed 24 h creatinine excretion rate (CER index)
was used as accurate marker of muscle mass.2
A 22-year-old Black male was diagnosed with terminal renal
insufficiency in May 1981. Chronic intermittent haemodialysis
was initiated and maintained until successful renal transplan-
tation in March 1982 (Figure 1A and 1B). At that time, body
Figure 1 Serum creatinine, body mass index, and height-indexed 24 h creatinine excretion rate over the course of the patient’s follow-up. Evolutions
in serum creatinine (A), CER index, and BMI (B) are shown over the course of follow-up. Moments of renal transplantation are represented by the
vertical dashed dark green lines, whereas moments of graft failure are represented by the vertical dashed red lines. The non-linear line represents
the estimated CER index, and the shaded area about the line the associated 95% pointwise confidence interval. The line is solid and coloured dark
green at follow-up times where CER index was actually observed, whereas the line is dashed and coloured dark red at periods of haemodialysis
(interpolation). Non-linearity was modelled using natural cubic splines with two knots imposed at 2.1 and 11.7 years of follow-up. Boundary knots
were set to the 5th and 95th percentiles of follow-up. The orange points through which the dark blue line is drawn represent observed BMIs. To
facilitate appraisal of serum concentrations of creatinine, CER indices, and BMIs around the third renal transplantation (i.e. the rightmost vertical
dashed dark green line), the range of the x and y axes of the original figure were cropped, and the resulting enlarged images are given in the upper
border of the plots. BMI, body mass index; CER index, height-indexed 24 h creatinine excretion rate.
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mass index (BMI) was 19.8 kg/m2 (Figure 1B). Serum
creatinine had remained steady until de novomembranous glo-
merulopathy ensued inMarch 1985 and eventually graft failure
inMay 1986. Deteriorating renal functionmanifested as a grad-
ual rise in serum creatinine (Figure 1A) and, interestingly, a con-
comitant decrease in CER index, indicating muscle wasting
from chronic kidney disease (Figure 1B). Six years of
haemodialysis followed until a second transplantation in June
1992. Importantly, CER index was considerably lower shortly af-
ter the second compared with the first transplantation (Figure
1B), whereas BMI had actually increased to 21.7 kg/m2 (Figure
1B). Eighteen months later, serum creatinine abruptly rose be-
cause of interstitial rejection and membranous glomerulopathy
(Figure 1A), whereafter haemodialysis was resumed in January
1994. During the years 1995–2003, complaints of generalized
arthropathy from haemodialysis-associated β-2 microglobulin
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amyloidosis gradually developed, which caused progressive de-
creases in mobility and, consequently, muscle mass and mani-
fested as concomitant decreases in serum creatinine and CER
index (Figure 1A and 1B). In December 2008, a third transplan-
tation was performed because of progressive amyloid arthrop-
athy. We observed an increase in BMI from 18.9 kg/m2 (first
day after transplantation) to 23.1 kg/m2 (19 days later at dis-
charge), and improved well-being was reported shortly after.
Remarkably, CER index had massively dropped to a quarter of
that in June 1992, indicating substantial muscle wasting. De-
spite increases in BMI in absence of oedema (beginning of Feb-
ruary 2009: 18.4 kg/m2; end of February 2009: 20.0 kg/m2;
March 2009: 20.2 kg/m2; June 2009: 20.9 kg/m2), CER index
steadily waned in the remaining months until the patient’s
death in August 2009 (Figure 1B).
Body mass index—defined as weight divided by height in
metres squared—is considered the ‘gold standard’ measure
of weight and hence abundantly used in clinical decision mak-
ing and research. In 1985, however, Andres and colleagues
called this concept into question by demonstrating that the
association between height-adjusted weight and mortality
follows a U-shaped curve. Moreover, the nadir of that curve
(i.e. the weight at which mortality rates were lowest) was
highly dependent on age.3 These findings gave rise to a con-
cept referred to as the ‘obesity paradox’, which still receives
much attention.4 We built on this concept with the patient’s
gradual, yet inexorable, wasting of muscle mass as harbinger
of deteriorating clinical condition and, eventually, death—all
in absence of declining BMI. This fuels the notion that muscle
mass is superior to BMI in mirroring clinical condition. Indeed,
the phenomenon of changing body composition with steady
(or even gained) weight can be explained by disproportionate
losses of lean mass and concurrent deposition of intramuscu-
lar adipose tissue.5 Additionally, the inexorable nature of the
observed muscle wasting indicates the difficulty of rebuilding
muscle after serious events. We urge that surrogates of
muscle mass, like CER index, as potentially superior prognosti-
cators of adverse outcome to BMI, be considered in study de-
sign and more frequently used to inform clinical decision
making in settings of low muscle mass or muscle wasting.
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